SAb Biotherapeutics Integrates Operations With New Production Facility Post author:Sam Post published:August 29, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Repros Therapeutics Reports Second Quarter 2017 Financial Results August 13, 2017 Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017 Bioverativ To Report Second Quarter 2017 Financial Results On August 2, 2017 July 6, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017